Pediatric CancerNCT07218328
Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinary Medicine Program (FoodiiS) Among Pediatric Cancer Survivors and Their Families
A study testing FoodiiS plus Culinary Essentials Food Delivery and Culinary Essentials Food Delivery Only in people with Pediatric Cancer, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
The goal of this research study is to learn if the FoodiiS-Kids intervention is useful to parents and guardians of pediatric cancer survivors. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Pediatric Cancer
- What is being tested?
- FoodiiS plus Culinary Essentials Food Delivery and Culinary Essentials Food Delivery Only
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 21 participants
- Where
- 1 siteUnited States
- Study dates
- 30 Dec 2026to 1 Jul 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Parents/guardians of school-aged (5-12 years) pediatric cancer survivors.
- Have children that are within five years of having completed active treatment.
- Self-report having internet access.
- Self-report as being able to speak and read English.
- Willing to complete study assessments.
Who cannot join
- Parents of pediatric cancer survivors over 12 years of age.
- Unwilling or unable to complete study assessments.
- Self-report to not speak English.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030
Margaret Raber, DRPH, mpraber@mdanderson.org
About this study
The goal of this research study is to learn if the FoodiiS-Kids intervention is useful to parents and guardians of pediatric cancer survivors.
Read the detailed description
Primary Objective:
Assess the feasibility and acceptability of the FoodiiS intervention for parents of pediatric cancer survivors (recruitment, retention, satisfaction).
Secondary Objective:
Explore the preliminary efficacy of FoodiiS to improve diet quality and cooking behaviors among parents of pediatric cancer survivor.
- Conditions
- Pediatric Cancer
- Being tested
- FoodiiS plus Culinary Essentials Food Delivery, Culinary Essentials Food Delivery Only, Waitlist control
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
FoodiiS plus Culinary Essentials Food DeliveryDietary supplement
The FoodiiS intervention will include videos, recipes, and other online healthy eating content adapted from previously developed materials.
Culinary Essentials Food Delivery OnlyDietary supplement
To support participants in effectively learning the healthy cooking strategies and mitigate access issues, investigators will provide participating families two home food deliveries of non-perishable culinary ingredients that are related to HCI practices including whole grain versions of common products (brown rice, whole wheat flour), healthier cooking oils (olive and canola), and a core selection of herbs and spices, among other goods.
Waitlist controlDietary supplement
The control group will receive no intervention until after T1. After the T1 data collection time point, the control group will receive all FoodiiS intervention materials.
| Study group | Role | What they receive |
|---|---|---|
| Waitlist Control (No Treatment until after T1 and then Access to all FoodiiS Materials) | Experimental | Target participants for this study will be parents/guardians of school-aged (5-12 years) pediatric cancer survivors that are within first 5 years off active treatment. Receives: Dietary Supplement: FoodiiS plus Culinary Essentials Food Delivery; Dietary Supplement: Waitlist control |
| FoodiiS (Digital Culnary Medicine Intervention + Culinary Essentials Food Delivery) | Experimental | Target participants for this study will be parents/guardians of school-aged (5-12 years) pediatric cancer survivors that are within first 5 years off active treatment. Receives: Dietary Supplement: Culinary Essentials Food Delivery Only |
| Culinary Essential Food Delivery Alone (No Other Intervention) | Experimental | Target participants for this study will be parents/guardians of school-aged (5-12 years) pediatric cancer survivors that are within first 5 years off active treatment. Receives: Dietary Supplement: Waitlist control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Safety and Adverse Events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Measured: Through study completion; an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Oct 2025
- Study start30 Dec 2026 (estimated)
- Primary completion1 Jul 2027 (estimated)
- Study completion1 Jul 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pediatric CancerStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 21 participants (estimated)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Marget Raber, DRPH, Principal investigator, M.D. Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07218328
- Sponsor's protocol ID
- 2025-1327
- Other IDs
- NCI-2025-07664
- Status last verified
- Jul 2026
- First submitted
- 16 Oct 2025
- Last updated
- 17 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinary Medicine Program (FoodiiS) Among Pediatric Cancer Survivors and Their Families
- ClinicalTrials.gov ID
- NCT07218328
- Acronym / sponsor ID
- 2025-1327
- Conditions
- Pediatric Cancer
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 21 participants (estimated)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Study start
- 30 Dec 2026 (estimated)
- Primary completion
- 1 Jul 2027 (estimated)
- Study completion
- 1 Jul 2029 (estimated)
- First posted
- 20 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this research study is to learn if the FoodiiS-Kids intervention is useful to parents and guardians of pediatric cancer survivors.
Detailed description
Primary Objective:
Assess the feasibility and acceptability of the FoodiiS intervention for parents of pediatric cancer survivors (recruitment, retention, satisfaction).
Secondary Objective:
Explore the preliminary efficacy of FoodiiS to improve diet quality and cooking behaviors among parents of pediatric cancer survivor.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Waitlist Control (No Treatment until after T1 and then Access to all FoodiiS Materials) | Experimental | Dietary Supplement: FoodiiS plus Culinary Essentials Food Delivery, Dietary Supplement: Waitlist controlTarget participants for this study will be parents/guardians of school-aged (5-12 years) pediatric cancer survivors that are within first 5 years off active treatment. |
| FoodiiS (Digital Culnary Medicine Intervention + Culinary Essentials Food Delivery) | Experimental | Dietary Supplement: Culinary Essentials Food Delivery OnlyTarget participants for this study will be parents/guardians of school-aged (5-12 years) pediatric cancer survivors that are within first 5 years off active treatment. |
| Culinary Essential Food Delivery Alone (No Other Intervention) | Experimental | Dietary Supplement: Waitlist controlTarget participants for this study will be parents/guardians of school-aged (5-12 years) pediatric cancer survivors that are within first 5 years off active treatment. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Parents/guardians of school-aged (5-12 years) pediatric cancer survivors.
- Have children that are within five years of having completed active treatment.
- Self-report having internet access.
- Self-report as being able to speak and read English.
- Willing to complete study assessments.
Key exclusion criteria (3 listed)
- Parents of pediatric cancer survivors over 12 years of age.
- Unwilling or unable to complete study assessments.
- Self-report to not speak English.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| FoodiiS plus Culinary Essentials Food DeliveryThe FoodiiS intervention will include videos, recipes, and other online healthy eating content adapted from previously developed materials. | Dietary supplement | Waitlist Control (No Treatment until after T1 and then Access to all FoodiiS Materials) |
| Culinary Essentials Food Delivery OnlyTo support participants in effectively learning the healthy cooking strategies and mitigate access issues, investigators will provide participating families two home food deliveries of non-perishable culinary ingredients that are related to HCI practices including whole grain versions of common products (brown rice, whole wheat flour), healthier cooking oils (olive and canola), and a core selection of herbs and spices, among other goods. | Dietary supplement | FoodiiS (Digital Culnary Medicine Intervention + Culinary Essentials Food Delivery) |
| Waitlist controlThe control group will receive no intervention until after T1. After the T1 data collection time point, the control group will receive all FoodiiS intervention materials. | Dietary supplement | Culinary Essential Food Delivery Alone (No Other Intervention), Waitlist Control (No Treatment until after T1 and then Access to all FoodiiS Materials) |
Primary outcome
Safety and Adverse Events (AEs)
Time frame: Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2026.
- MD Anderson Cancer Center WebsiteLink provided by the sponsor.
Related trials for Pediatric Cancer
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
RecruitingPhase 1/2
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Myelodysplastic Syndromes
RecruitingObservational study
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
Pediatric Cancer
Active, not recruitingPhase 3
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
RecruitingObservational study
The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
Knowledge, Attitudes, Practice
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Marget Raber, DRPH principal investigator
M.D. Anderson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing FoodiiS plus Culinary Essentials Food Delivery and Culinary Essentials Food Delivery Only in people with Pediatric Cancer, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Margaret Raber, DRPH (713-792-9861, mpraber@mdanderson.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Safety and Adverse Events (AEs) (time frame: Through study completion; an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026; AzTrials last refreshed its copy on 8 Nov 2026.